Tooth loss associated with the use of tenofovir disoproxil fumarate
Journal: 2020/August - Journal of Clinical Pharmacy and Therapeutics
Abstract:
What is known and objective: The frequent tenofovir disoproxil fumarate (TDF)-related adverse drug reactions (ADRs) are nephrotoxicity and bone toxicity; however, tooth-related ADRs of TDF have not been reported. We describe the case of a 41-year-old Han Chinese man with chronic hepatitis B with TDF-associated tooth loss.
Case summary: He presented with halitosis, gingival swelling and tooth loss after TDF use. After excluding the possibility of other drug-related ADRs, TDF was considered a possible cause and switched with tenofovir alafenamide fumarate (TAF). After 6 months, the oral symptoms disappeared, with no additional tooth loss.
What is new and conclusion: This is the first report of such ADRs. The ADR score was 7, indicating tooth loss as a potential TDF-related ADR.
Keywords: adverse reaction; chronic hepatitis B; tenofovir alafenamide fumarate; tenofovir disoproxil fumarate.
Relations:
Diseases
(3)
Conditions
(1)
Drugs
(1)
Chemicals
(3)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.